Tissue Regeneration Technologies, LLC

Tissue Regeneration Technologies, LLC — FDA 510(k) Submissions

Tissue Regeneration Technologies, LLC has submitted 2 FDA 510(k) premarket notifications since 2020, of which 2 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Extracorporeal Shock Wave Device For Treatment Of Diabetic Foot Ulcers, Massager, Therapeutic, Electric . Use the specialty filter in the sidebar to narrow results.